1991
DOI: 10.1016/0360-3016(91)90332-x
|View full text |Cite
|
Sign up to set email alerts
|

Radiation sensitivity of human B-lineage lymphoid precursor cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
7
0
1

Year Published

1992
1992
2011
2011

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(9 citation statements)
references
References 40 publications
1
7
0
1
Order By: Relevance
“…MSH2 has been implicated in a variety of processes that serve to protect the genome integrity like DNA repair, cell cycle checkpoints and apoptosis [22]. The specific protein has been shown to be implicated also in several other pathways like DSB repair [24] and has been associated with radiosensitivity and accumulation of oxidative DNA lesions like 8-oxodG [25][26][27][28]. Defects in MSH2 have been associated with several childhood leukemias including ALL [29,30].…”
Section: Introductionmentioning
confidence: 99%
“…MSH2 has been implicated in a variety of processes that serve to protect the genome integrity like DNA repair, cell cycle checkpoints and apoptosis [22]. The specific protein has been shown to be implicated also in several other pathways like DSB repair [24] and has been associated with radiosensitivity and accumulation of oxidative DNA lesions like 8-oxodG [25][26][27][28]. Defects in MSH2 have been associated with several childhood leukemias including ALL [29,30].…”
Section: Introductionmentioning
confidence: 99%
“…We used the fetal liver pro-B cell line FL112, the pre-pre-B cell line Reh, the pre-B cell line Nalm-6, and the early B/Burkitt lymphoma cell lines Daudi, Ramos, and Ramos-1 (a subclone of Ramos). The immunophenotypic and genotypic features and the radiation sensitivity of these human B-lymphocyte precursor cell lines were detailed in a previous report (8). We also used primary bone marrow blasts from a pre-pre-B acute lymphoblastic leukemia patient (UPN10), following the guidelines of the University of Minnesota Committee on the Use of Human Subjects in Research for secondary use of pathologic or surgical tissue.…”
Section: Methodsmentioning
confidence: 99%
“…Cells (5 x i05 per ml in plastic tissue culture flasks) were irradiated (137Cs irradiator; J. L. Shephard, Glendale, CA, model Mark I) with 100-400 cGy at a dose rate of 99 cGy/min during logarithmic phase and under aerobic conditions, as previously described (8,9). Prior to irradiation, cells were incubated for 1 hr at 37°C with (a) phosphate-buffered saline, (b) the PTK inhibitor genistein ,g/ml = 37-370 ,uM; ICN), (c) the protein kinase C inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7; 11 ,ug/ml = 30 ,M; GIBCO BRL), or (d) the protein-tyrosine-phosphatase (PTPase) inhibitor sodium orthovanadate (10-100 ,M, Sigma) or for 24 hr at 37°C with the benzoquinoid ansamycin antibiotic herbimycin A (7 ,g/ml = 12 ,uM; GIBCO/BRL), a potent PTK inhibitor, using previously described protocols (6,7).…”
Section: Methodsmentioning
confidence: 99%
“…Lymphomas often die by apoptosis, but the clonogenic survival differs considerably between tumors of this type. 3,4 More knowledge about the molecular mechanisms underlying these differences in radiosensitivity would be useful in the design of improved treatment strategies based on IR for lymphomas. 5 The radiation response is thought to be the result of changes in the transcription of genes that are involved in DNA repair, cell cycle checkpoints and induction of cell death.…”
mentioning
confidence: 99%